<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Reporting rates of events or substances — reporting_rates • DiAna</title><!-- favicons --><link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png"><link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png"><link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png"><link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png"><link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png"><link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png"><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Reporting rates of events or substances — reporting_rates"><meta name="description" content="counts the occurrences of reactions/indications/substance
for a given set of primary IDs.
Calculates % as the proportion of individuals recording the event."><meta property="og:description" content="counts the occurrences of reactions/indications/substance
for a given set of primary IDs.
Calculates % as the proportion of individuals recording the event."><meta property="og:image" content="https://fusarolimichele.github.io/DiAna_package/logo.png"></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">DiAna</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">2.1.0</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles"><li><hr class="dropdown-divider"></li>
    <li><h6 class="dropdown-header" data-toc-skip>Get started</h6></li>
    <li><a class="dropdown-item" href="../articles/Start_Subproject.html">Start Subproject</a></li>
    <li><hr class="dropdown-divider"></li>
    <li><h6 class="dropdown-header" data-toc-skip>Disproportionality Analysis</h6></li>
    <li><a class="dropdown-item" href="../articles/Disproportionality_Analysis.html">Disproportionality Analysis</a></li>
    <li><a class="dropdown-item" href="../articles/Causal_inference.html">Causal inference</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json"></form></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/fusarolimichele/DiAna_package/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.png" class="logo" alt=""><h1>Reporting rates of events or substances</h1>
      <small class="dont-index">Source: <a href="https://github.com/fusarolimichele/DiAna_package/blob/main/R/count_reactions.R" class="external-link"><code>R/count_reactions.R</code></a></small>
      <div class="d-none name"><code>reporting_rates.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>counts the occurrences of reactions/indications/substance
for a given set of primary IDs.
Calculates % as the proportion of individuals recording the event.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">reporting_rates</span><span class="op">(</span></span>
<span>  <span class="va">pids_cases</span>,</span>
<span>  entity <span class="op">=</span> <span class="st">"reaction"</span>,</span>
<span>  level <span class="op">=</span> <span class="st">"pt"</span>,</span>
<span>  drug_role <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"PS"</span>, <span class="st">"SS"</span>, <span class="st">"I"</span>, <span class="st">"C"</span><span class="op">)</span>,</span>
<span>  drug_indi <span class="op">=</span> <span class="cn">NA</span>,</span>
<span>  temp_reac <span class="op">=</span> <span class="va">Reac</span>,</span>
<span>  temp_drug <span class="op">=</span> <span class="va">Drug</span>,</span>
<span>  temp_indi <span class="op">=</span> <span class="va">Indi</span></span>
<span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>


<dl><dt id="arg-pids-cases">pids_cases<a class="anchor" aria-label="anchor" href="#arg-pids-cases"></a></dt>
<dd><p>Vector of primary IDs to consider for counting reactions.</p></dd>


<dt id="arg-entity">entity<a class="anchor" aria-label="anchor" href="#arg-entity"></a></dt>
<dd><p>Entity investigated. It can be one of the following:</p><ul><li><p><em>reaction</em>;</p></li>
<li><p><em>indication</em>;</p></li>
<li><p><em>substance</em>.</p></li>
</ul></dd>


<dt id="arg-level">level<a class="anchor" aria-label="anchor" href="#arg-level"></a></dt>
<dd><p>The desired MedDRA or ATC level for counting (default is "pt").</p></dd>


<dt id="arg-drug-role">drug_role<a class="anchor" aria-label="anchor" href="#arg-drug-role"></a></dt>
<dd><p>is only used for substances. By default both suspect and concomitant drugs are included.</p></dd>


<dt id="arg-drug-indi">drug_indi<a class="anchor" aria-label="anchor" href="#arg-drug-indi"></a></dt>
<dd><p>is only used for indications. By default the indications of all the drugs of the selected primaryids are considered, but you can specify a vector of drugs.</p></dd>


<dt id="arg-temp-reac">temp_reac<a class="anchor" aria-label="anchor" href="#arg-temp-reac"></a></dt>
<dd><p>Reac dataset. Can be set to sample_Reac for testing</p></dd>


<dt id="arg-temp-drug">temp_drug<a class="anchor" aria-label="anchor" href="#arg-temp-drug"></a></dt>
<dd><p>Drug dataset. Can be set to sample_Drug for testing</p></dd>


<dt id="arg-temp-indi">temp_indi<a class="anchor" aria-label="anchor" href="#arg-temp-indi"></a></dt>
<dd><p>Indi dataset. Can be set to sample_Indi for testing</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    <p>A data.table containing counts and percentages of the investigated entity
at the specified level and in descending order.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="co"># select only reports recording paracetamol from the sample dataset,</span></span></span>
<span class="r-in"><span><span class="co"># and provide the most reported events (at the pt level),</span></span></span>
<span class="r-in"><span><span class="co"># drugs, and indications (at the PT level).</span></span></span>
<span class="r-in"><span><span class="va">pids_cases</span> <span class="op">&lt;-</span></span></span>
<span class="r-in"><span><span class="fu">reporting_rates</span><span class="op">(</span><span class="fu"><a href="https://rdrr.io/r/base/unique.html" class="external-link">unique</a></span><span class="op">(</span><span class="va">sample_Drug</span><span class="op">[</span><span class="va">substance</span> <span class="op">==</span> <span class="st">"paracetamol"</span><span class="op">]</span><span class="op">$</span><span class="va">primaryid</span><span class="op">)</span>,</span></span>
<span class="r-in"><span> <span class="st">"reaction"</span>, <span class="st">"pt"</span>,</span></span>
<span class="r-in"><span>  temp_reac <span class="op">=</span> <span class="va">sample_Reac</span>,</span></span>
<span class="r-in"><span>  temp_drug <span class="op">=</span> <span class="va">sample_Drug</span>, temp_indi <span class="op">=</span> <span class="va">sample_Indi</span></span></span>
<span class="r-in"><span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="fu">reporting_rates</span><span class="op">(</span><span class="fu"><a href="https://rdrr.io/r/base/unique.html" class="external-link">unique</a></span><span class="op">(</span><span class="va">sample_Drug</span><span class="op">[</span><span class="va">substance</span> <span class="op">==</span> <span class="st">"paracetamol"</span><span class="op">]</span><span class="op">$</span><span class="va">primaryid</span><span class="op">)</span>,</span></span>
<span class="r-in"><span>  <span class="st">"indication"</span>, <span class="st">"pt"</span>,</span></span>
<span class="r-in"><span>  temp_reac <span class="op">=</span> <span class="va">sample_Reac</span>,</span></span>
<span class="r-in"><span>  temp_drug <span class="op">=</span> <span class="va">sample_Drug</span>, temp_indi <span class="op">=</span> <span class="va">sample_Indi</span></span></span>
<span class="r-in"><span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                    pt</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 &lt;ord&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  1:                              pain</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  2:              rheumatoid arthritis</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  3:                         back pain</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  4:                           anxiety</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  5:  gastrooesophageal reflux disease</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  6:                        depression</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  7:                      hypertension</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  8:               plasma cell myeloma</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9:                         psoriasis</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10:                            asthma</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 11:          type 2 diabetes mellitus</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 12:                     premedication</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 13:                          covid-19</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 14:             psoriatic arthropathy</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 15:                affective disorder</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 16:                psychotic disorder</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 17:           intentional self-injury</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 18:                 candida infection</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 19:              ill-defined disorder</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 20: low density lipoprotein increased</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 21:              abdominal pain upper</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 22:                     muscle spasms</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 23:                         neuralgia</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 24:                 breakthrough pain</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 25:                          migraine</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 26:                          insomnia</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 27:      systemic lupus erythematosus</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 28:                      chemotherapy</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 29:                  hypersensitivity</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 30:                     contraception</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 31:          mucopolysaccharidosis vi</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 32:         chronic myeloid leukaemia</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 33:                multiple sclerosis</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 34:             oral fungal infection</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 35:               atrial fibrillation</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 36:                postoperative care</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 37:        cardiac failure congestive</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 38:                          cachexia</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 39:                       tonsillitis</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 40:                         dyspepsia</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 41:                              gout</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 42:                calcium deficiency</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 43:              vitamin d deficiency</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 44:                  blood phosphorus</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 45:                     renal failure</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 46:                           anaemia</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 47:                        leukopenia</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 48:                   crohn's disease</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 49:             infection prophylaxis</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 50:        essential thrombocythaemia</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 51:  immunodeficiency common variable</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 52:           acute myeloid leukaemia</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 53:              pancreatic carcinoma</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 54:            influenza like illness</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 55:                           pyrexia</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 56:                            chills</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 57:                         infection</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 58:           blood pressure abnormal</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 59:                      renal injury</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 60:        blood cholesterol abnormal</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 61:                  cardiac disorder</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 62:                             cough</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 63:                       rhinorrhoea</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 64:       upper-airway cough syndrome</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 65:                   fabry's disease</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 66:                colitis ulcerative</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 67:             covid-19 immunisation</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                    pt</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                          label_pt  N_pt</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                            &lt;char&gt; &lt;int&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  1:                             pain (17.95%) [7]     7</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  2:              rheumatoid arthritis (7.69%) [3]     3</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  3:                         back pain (7.69%) [3]     3</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  4:                           anxiety (7.69%) [3]     3</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  5:  gastrooesophageal reflux disease (7.69%) [3]     3</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  6:                        depression (7.69%) [3]     3</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  7:                      hypertension (5.13%) [2]     2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  8:               plasma cell myeloma (5.13%) [2]     2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9:                         psoriasis (5.13%) [2]     2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10:                            asthma (5.13%) [2]     2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 11:          type 2 diabetes mellitus (5.13%) [2]     2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 12:                     premedication (5.13%) [2]     2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 13:                          covid-19 (5.13%) [2]     2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 14:             psoriatic arthropathy (5.13%) [2]     2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 15:                affective disorder (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 16:                psychotic disorder (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 17:           intentional self-injury (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 18:                 candida infection (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 19:              ill-defined disorder (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 20: low density lipoprotein increased (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 21:              abdominal pain upper (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 22:                     muscle spasms (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 23:                         neuralgia (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 24:                 breakthrough pain (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 25:                          migraine (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 26:                          insomnia (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 27:      systemic lupus erythematosus (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 28:                      chemotherapy (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 29:                  hypersensitivity (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 30:                     contraception (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 31:          mucopolysaccharidosis vi (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 32:         chronic myeloid leukaemia (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 33:                multiple sclerosis (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 34:             oral fungal infection (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 35:               atrial fibrillation (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 36:                postoperative care (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 37:        cardiac failure congestive (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 38:                          cachexia (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 39:                       tonsillitis (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 40:                         dyspepsia (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 41:                              gout (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 42:                calcium deficiency (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 43:              vitamin d deficiency (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 44:                  blood phosphorus (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 45:                     renal failure (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 46:                           anaemia (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 47:                        leukopenia (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 48:                   crohn's disease (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 49:             infection prophylaxis (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 50:        essential thrombocythaemia (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 51:  immunodeficiency common variable (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 52:           acute myeloid leukaemia (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 53:              pancreatic carcinoma (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 54:            influenza like illness (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 55:                           pyrexia (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 56:                            chills (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 57:                         infection (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 58:           blood pressure abnormal (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 59:                      renal injury (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 60:        blood cholesterol abnormal (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 61:                  cardiac disorder (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 62:                             cough (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 63:                       rhinorrhoea (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 64:       upper-airway cough syndrome (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 65:                   fabry's disease (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 66:                colitis ulcerative (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 67:             covid-19 immunisation (2.56%) [1]     1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                          label_pt  N_pt</span>
<span class="r-in"><span><span class="fu">reporting_rates</span><span class="op">(</span><span class="fu"><a href="https://rdrr.io/r/base/unique.html" class="external-link">unique</a></span><span class="op">(</span><span class="va">sample_Drug</span><span class="op">[</span><span class="va">substance</span> <span class="op">==</span> <span class="st">"paracetamol"</span><span class="op">]</span><span class="op">$</span><span class="va">primaryid</span><span class="op">)</span>,</span></span>
<span class="r-in"><span>  entity <span class="op">=</span> <span class="st">"substance"</span>,</span></span>
<span class="r-in"><span>  temp_reac <span class="op">=</span> <span class="va">sample_Reac</span>, temp_drug <span class="op">=</span> <span class="va">sample_Drug</span>,</span></span>
<span class="r-in"><span>  temp_indi <span class="op">=</span> <span class="va">sample_Indi</span></span></span>
<span class="r-in"><span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 substance                    label_substance N_substance</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                    &lt;fctr&gt;                             &lt;char&gt;       &lt;int&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   1:          paracetamol            paracetamol (100%) [51]          51</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   2:            oxycodone            oxycodone (31.37%) [16]          16</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   3:          hydrocodone          hydrocodone (25.49%) [13]          13</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   4: acetylsalicylic acid acetylsalicylic acid (19.61%) [10]          10</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   5:           salbutamol            salbutamol (17.65%) [9]           9</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  ---                                                                    </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 264:            enalapril              enalapril (1.96%) [1]           1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 265:            aciclovir              aciclovir (1.96%) [1]           1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 266:           nifedipine             nifedipine (1.96%) [1]           1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 267:         upadacitinib           upadacitinib (1.96%) [1]           1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 268:     covid-19 vaccine       covid-19 vaccine (1.96%) [1]           1</span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by Michele Fusaroli, Valentina Giunchi.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.1.</p>
</div>

    </footer></div>





  </body></html>

